Bright Green Company Overview

Bright Green  logo
Bright Green
Bright Green  primary media

About Bright Green

Bright Green (NASDAQ:BGXX) specializes in the controlled environment agriculture of pharmaceutical-grade cannabis for research and medicinal purposes. With a commitment to advancing clinical research and supporting patients with therapeutic needs, Bright Green engages in the cultivation, extraction, and distribution of high-quality cannabis products. The company's projects are mainly focused on developing sustainable cultivation techniques and expanding its product portfolio to meet the growing demand in the medicinal cannabis market. Bright Green aims to set new standards in the industry by adhering to rigorous quality control measures and contributing to scientific research that can unlock the potential benefits of cannabis for various medical conditions.

What is Bright Green known for?

Snapshot

2019
Year founded
5
Employees
Florida, United States
Head office
Loading Map...

Operations

All Locations
United States

Produtos e/ou serviços de Bright Green

  • Cultivation and sale of federally compliant cannabis for research and pharmaceutical applications.
  • Development of proprietary genetics for cannabis plants to ensure quality and consistency.
  • Investment in advanced greenhouse technology for sustainable and efficient cannabis production.
  • Online platform for the legal distribution and sale of cannabis products for medical research.
  • Partnerships with universities and medical institutions for cannabis-related research and development.
  • Consulting services for businesses navigating the regulatory landscape of the cannabis industry.

equipe executiva do Bright Green

  • Ms. Lynn StockwellCo-Founder, CEO & Chair of the Board

Connect with us

Disclaimer

Grafa is not a financial advisor. You should seek independent, legal, financial, taxation or other advice that relate to your unique circumstances.

Grafa is not liable for any loss caused, whether due to negligence or otherwise arising from the use of or reliance on the information provided directly or indirectly, by use of this platform.